Insider · CIK 0001177079

MARTELL RON

Reports to the SEC for 7 companies · SO. SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001177079

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-02	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President, CEO and Director	AAward	+234K sh	—	—	234,000
2025-09-22	JSPRJasper Therapeutics, Inc.P Purchase	Director, President, CEO and Director	PPurchase	+41K sh	$2.43	+$99.6K	74,118
2025-09-22	JSPRJasper Therapeutics, Inc. · Common Stock Warrant (right to buy)P Purchase	Director, President, CEO and Director	PPurchase	+41K sh	—	—	41,000
2025-06-04	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President, CEO and Director	AAward	+234K sh	—	—	234,000
2025-02-13	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President, CEO and Director	AAward	+130K sh	—	—	130,000
2024-06-10	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President, CEO and Director	AAward	+10K sh	—	—	10,000
2024-06-10	JSPRJasper Therapeutics, Inc. · Performance Restricted Stock UnitsA Award	Director, President, CEO and Director	AAward	+20K sh	—	—	20,000
2024-02-15	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President, CEO and Director	AAward	+100K sh	—	—	100,000
2023-10-12	JSPRJasper Therapeutics, Inc.F Tax Payment	Director, President, CEO and Director	FTax Payment	−87.5K sh	$0.85	−$74.4K	331,188
2023-04-12	JSPRJasper Therapeutics, Inc.F Tax Payment	Director, President, CEO and Director	FTax Payment	−87.5K sh	$1.46	−$128K	418,719
2023-03-17	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President, CEO and Director	AAward	+500K sh	—	—	500,000
2023-02-02	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President, CEO and Director	AAward	+1.09M sh	—	—	1,093,831
2022-10-12	JSPRJasper Therapeutics, Inc.A Award	Director, President, CEO and Director	AAward	+506K sh	—	—	506,250
2022-03-21	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President, CEO and Director	AAward	+1.7M sh	—	—	1,704,328
2017-01-26	CNSYCERENOME, INC. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2015-10-28	HUMANIGEN, INCStock Option (right to buy)A Award	Director, Executive Chairman	AAward	+3,125 sh	—	—	3,125
2015-09-28	HUMANIGEN, INCStock Option (right to buy)A Award	Director, Executive Chairman	AAward	+3,125 sh	—	—	3,125
2015-08-28	HUMANIGEN, INCStock Option (right to buy)A Award	Director, Executive Chairman	AAward	+3,125 sh	—	—	3,125
2015-07-30	HUMANIGEN, INCStock Option (right to buy)A Award	Director, Executive Chairman	AAward	+3,125 sh	—	—	3,125
2015-06-29	HUMANIGEN, INCStock Option (right to buy)A Award	Director, Executive Chairman	AAward	+25K sh	—	—	25,000
2015-05-28	HUMANIGEN, INCStock Option (right to buy)A Award	Director, Executive Chairman	AAward	+25K sh	—	—	25,000
2015-04-22	HUMANIGEN, INCRestricted Stock UnitsA Award	Director, Executive Chairman	AAward	+30K sh	—	—	30,000
2015-04-22	HUMANIGEN, INCStock Option (right to buy)A Award	Director, Executive Chairman	AAward	+30K sh	—	—	30,000
2014-11-18	ELOXEloxx Pharmaceuticals, Inc. · Common Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+56.4K sh	—	—	456,364
2013-01-01	NeurogesX IncM Exercise/Conversion	President and CEO	MExercise/Conversion	+25K sh	—	—	25,000
2013-01-01	NeurogesX IncRestricted Stock UnitsM Exercise/Conversion	President and CEO	MExercise/Conversion	−25K sh	—	—	75,000
2012-03-13	NeurogesX IncStock Option (right to buy)A Award	President and CEO	AAward	−300K sh	—	—	300,000
2012-03-13	NeurogesX IncStock Option (right to buy)A Award	President and CEO	AAward	−300K sh	—	—	300,000
2012-01-30	NeurogesX IncNonstatutory stock option (right to buy)A Award	President and CEO	AAward	+500K sh	—	—	500,000
2012-01-30	NeurogesX IncRestricted Stock UnitsA Award	President and CEO	AAward	+100K sh	—	—	100,000
2012-01-30	NeurogesX IncNonstatutory stock option (right to buy)A Award	President and CEO	AAward	+500K sh	—	—	500,000
2012-01-30	NeurogesX IncRestricted Stock UnitsA Award	President and CEO	AAward	+100K sh	—	—	100,000
2011-10-06	PONIARD PHARMACEUTICALS, INC.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+25K sh	—	—	548,073
2011-10-06	PONIARD PHARMACEUTICALS, INC.Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−25K sh	—	—	50,000
2011-04-09	PONIARD PHARMACEUTICALS, INC.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+163K sh	—	—	523,073
2011-04-09	PONIARD PHARMACEUTICALS, INC.Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−163K sh	—	—	162,500
2011-02-15	PONIARD PHARMACEUTICALS, INC.Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+577K sh	—	—	576,924
2011-02-07	PONIARD PHARMACEUTICALS, INC.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+31.3K sh	—	—	360,573
2011-02-07	PONIARD PHARMACEUTICALS, INC.Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−31.3K sh	—	—	93,750
2010-12-31	PONIARD PHARMACEUTICALS, INC.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+292K sh	—	—	304,323
2010-12-31	PONIARD PHARMACEUTICALS, INC.Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−292K sh	—	—	0
2010-10-06	PONIARD PHARMACEUTICALS, INC.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+25K sh	—	—	329,323
2010-10-06	PONIARD PHARMACEUTICALS, INC.Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−25K sh	—	—	75,000
2010-06-09	PONIARD PHARMACEUTICALS, INC.Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+250K sh	—	—	250,000
2010-04-09	PONIARD PHARMACEUTICALS, INC.Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+325K sh	—	—	1,675,541
2010-03-25	PONIARD PHARMACEUTICALS, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+1,200 sh	$1.26	+$1,512	1,200
2010-03-25	PONIARD PHARMACEUTICALS, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+10.9K sh	$1.24	+$13.5K	12,115
2010-02-04	PONIARD PHARMACEUTICALS, INC.Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+292K sh	—	—	1,350,541
2009-10-06	PONIARD PHARMACEUTICALS, INC.Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	1,058,333
2008-01-03	PONIARD PHARMACEUTICALS, INC.Stock OptionA Award	Director, Chief Executive Officer	AAward	+75K sh	$4.18	+$314K	75,000

Recent filings

Accepted (ET)
Jan 54
MARTELL RON0001213900-26-001385
SEC(opens sec.gov)
Sep 244
MARTELL RON0001213900-25-091099
SEC(opens sec.gov)
Jun 64
MARTELL RON0001213900-25-051729
SEC(opens sec.gov)
Feb 184
MARTELL RON0001213900-25-014950
SEC(opens sec.gov)
Jun 124
MARTELL RON0001213900-24-052087
SEC(opens sec.gov)
Feb 204
MARTELL RON0001213900-24-015465
SEC(opens sec.gov)
Oct 134
MARTELL RON0001013762-23-003902
SEC(opens sec.gov)
Apr 144
MARTELL RON0001213900-23-029896
SEC(opens sec.gov)
Mar 204
MARTELL RON0001213900-23-021493
SEC(opens sec.gov)
Feb 34
MARTELL RON0001213900-23-007992
SEC(opens sec.gov)
Oct 134
MARTELL RON0001213900-22-063949
SEC(opens sec.gov)
Mar 234
MARTELL RON0001213900-22-014572
SEC(opens sec.gov)
Jan 274
CYTORI THERAPEUTICS, INC.0001209191-17-005970
SEC(opens sec.gov)
Oct 284
KALOBIOS PHARMACEUTICALS INC0001209191-15-077210
SEC(opens sec.gov)
Sep 284
KALOBIOS PHARMACEUTICALS INC0001209191-15-072349
SEC(opens sec.gov)
Sep 224
KALOBIOS PHARMACEUTICALS INC0001209191-15-071885
SEC(opens sec.gov)
Jul 304
KALOBIOS PHARMACEUTICALS INC0001209191-15-063026
SEC(opens sec.gov)
Jun 304
KALOBIOS PHARMACEUTICALS INC0001209191-15-057455
SEC(opens sec.gov)

Companies

Address

7000 SHORELINE COURT STE. 270

SO. SAN FRANCISCO, CA, 94080-1957